• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗前影像学检查显示淋巴结肿大作为临床IIB期宫颈癌的重要预后因素:来自台湾一家三级医疗中心的共识证据

Pretreatment Radiologically Enlarged Lymph Nodes as a Significant Prognostic Factor in Clinical Stage IIB Cervical Cancer: Evidence from a Taiwanese Tertiary Care Center in Reaching Consensus.

作者信息

Liu Chia-Hao, Yang Szu-Ting, Chao Wei-Ting, Lin Jeff Chien-Fu, Lee Na-Rong, Chang Wen-Hsun, Chen Yi-Jen, Wang Peng-Hui

机构信息

Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei 112, Taiwan.

Department of Obstetrics and Gynecology, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.

出版信息

Diagnostics (Basel). 2022 May 14;12(5):1230. doi: 10.3390/diagnostics12051230.

DOI:10.3390/diagnostics12051230
PMID:35626385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9140083/
Abstract

The incidence of lymph node (LN) involvement and its prognostic value based on radiological imaging in stage IIB cervical cancer (CC) remains unclear, and evidence regarding oncological outcomes of patients with stage IIB CC with LN metastases is limited. In this study we retrospectively reviewed the incidence and prognostic significance of pretreatment radiologic LN status in 72 patients with clinical stage IIB CC (FIGO 2009), with or without radiologic evidence of LN enlargement. An enlarged LN was defined as a diameter > 10 mm on CT/MRI. Progression-free survival (PFS) and overall survival (OS) were assessed. Radiologic LN enlargement of >10 mm was observed in 45.8% of patients with stage IIB CC. PFS (p = 0.0088) and OS rates (p = 0.0032) were significantly poorer in the LN group (n = 33) than in the non-LN group (n = 39). Univariate Cox analysis revealed that LN > 10 mm contributed to a higher rate of recurrence and mortality. In conclusion, nearly half of the patients with clinical stage IIB CC had enlarged LNs (>10 mm) identified during pretreatment radiologic evaluation, which negatively impacted prognosis. Our findings highlight the need to incorporate CT- or MRI-based LN assessment before treatment for stage IIB CC.

摘要

基于影像学检查的IIB期宫颈癌(CC)患者淋巴结(LN)转移发生率及其预后价值仍不明确,关于IIB期CC伴LN转移患者肿瘤学结局的证据有限。在本研究中,我们回顾性分析了72例临床IIB期CC(FIGO 2009)患者治疗前影像学LN状态的发生率及预后意义,这些患者有无LN增大的影像学证据。CT/MRI上直径>10 mm的LN定义为增大的LN。评估无进展生存期(PFS)和总生存期(OS)。IIB期CC患者中45.8%观察到影像学LN增大>10 mm。LN组(n = 33)的PFS(p = 0.0088)和OS率(p = 0.0032)显著低于非LN组(n = 39)。单因素Cox分析显示,LN>10 mm导致更高的复发率和死亡率。总之,近一半的临床IIB期CC患者在治疗前影像学评估中发现LN增大(>10 mm),这对预后有负面影响。我们的研究结果强调了在IIB期CC治疗前纳入基于CT或MRI的LN评估的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fcc/9140083/f7864e04bda9/diagnostics-12-01230-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fcc/9140083/f7864e04bda9/diagnostics-12-01230-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fcc/9140083/f7864e04bda9/diagnostics-12-01230-g001.jpg

相似文献

1
Pretreatment Radiologically Enlarged Lymph Nodes as a Significant Prognostic Factor in Clinical Stage IIB Cervical Cancer: Evidence from a Taiwanese Tertiary Care Center in Reaching Consensus.治疗前影像学检查显示淋巴结肿大作为临床IIB期宫颈癌的重要预后因素:来自台湾一家三级医疗中心的共识证据
Diagnostics (Basel). 2022 May 14;12(5):1230. doi: 10.3390/diagnostics12051230.
2
Prognostic Factors of Cervical Adenocarcinoma With Positive Pelvic Lymph Node Metastases Without Preoperative Lymph Node Enlargement Treated With Radical Hysterectomy.根治性子宫切除术治疗术前未出现淋巴结肿大但盆腔淋巴结转移阳性的宫颈腺癌的预后因素
Cancer Diagn Progn. 2023 Jan 3;3(1):96-101. doi: 10.21873/cdp.10185. eCollection 2023 Jan-Feb.
3
Prognostic value of radiologically enlarged lymph nodes in node-negative colon cancer.影像学显示肿大淋巴结在无淋巴结转移结肠癌中的预后价值
Colorectal Dis. 2020 May;22(5):537-543. doi: 10.1111/codi.14938. Epub 2020 Jan 9.
4
Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.淋巴结阴性Ⅰ期-ⅡA 期宫颈癌根治性子宫切除术后无病生存预测的术后列线图。
J Obstet Gynaecol. 2020 Jul;40(5):699-704. doi: 10.1080/01443615.2019.1652888. Epub 2019 Oct 12.
5
Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy.MRI 评估的肿瘤体积和淋巴结受累在同期放化疗治疗 IIB 期宫颈癌患者中的临床意义。
J Gynecol Oncol. 2010 Mar;21(1):18-23. doi: 10.3802/jgo.2010.21.1.18. Epub 2010 Mar 31.
6
Feasibility of radical hysterectomy in women with FIGO stage IIB cervical cancer: an observation study of 10-year experience in a tertiary center.FIGO IIB期宫颈癌患者行根治性子宫切除术的可行性:一项在三级中心开展的为期10年经验的观察性研究
Onco Targets Ther. 2018 Sep 19;11:5527-5533. doi: 10.2147/OTT.S173208. eCollection 2018.
7
Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on F-FDG PET/CT in Patients With Limited-stage Small-cell Lung Cancer With Lymph Node Involvement.局限期小细胞肺癌伴淋巴结转移患者 F-FDG PET/CT 转移淋巴结代谢参数的预后价值。
Clin Lung Cancer. 2018 Jan;19(1):e101-e108. doi: 10.1016/j.cllc.2017.06.006. Epub 2017 Jun 22.
8
Do clinical characteristics and metabolic markers detected on positron emission tomography/computerized tomography associate with persistent disease in patients with in-operable cervical cancer?正电子发射断层扫描/计算机断层扫描检测到的临床特征和代谢标志物与不能手术的宫颈癌患者的持续性疾病有关吗?
Ann Nucl Med. 2013 Oct;27(8):756-63. doi: 10.1007/s12149-013-0745-1. Epub 2013 Jun 21.
9
Prognostic Value of Log Odds of Positive Lymph Nodes after Radical Surgery Followed by Adjuvant Treatment in High-Risk Cervical Cancer.根治性手术后辅助治疗中阳性淋巴结对数优势比对高危宫颈癌的预后价值。
Cancer Res Treat. 2016 Apr;48(2):632-40. doi: 10.4143/crt.2015.085. Epub 2015 Jul 14.
10
The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.基于盆腔淋巴结特征对接受同步放化疗的局部晚期宫颈鳞状细胞癌患者的预后及风险分层
Int J Gynecol Cancer. 2016 Oct;26(8):1472-9. doi: 10.1097/IGC.0000000000000778.

本文引用的文献

1
Is the pathologic tumor size associated with survival in early cervical cancer treated with radical hysterectomy and adjuvant radiotherapy?根治性子宫切除术和辅助放疗治疗早期宫颈癌时,肿瘤病理大小与生存相关吗?
Taiwan J Obstet Gynecol. 2022 Mar;61(2):329-332. doi: 10.1016/j.tjog.2022.02.023.
2
Neurogenic bladder in patients with cervical cancer after treatment.宫颈癌患者治疗后的神经源性膀胱
J Chin Med Assoc. 2022 Jan 1;85(1):1-2. doi: 10.1097/JCMA.0000000000000620.
3
Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system.
根据 2018 年 FIGO 分期系统对接受根治性子宫切除术治疗的宫颈癌病例进行重新分类。
Taiwan J Obstet Gynecol. 2021 Nov;60(6):1054-1058. doi: 10.1016/j.tjog.2021.09.016.
4
Synergistic therapeutic effect of low-dose bevacizumab with cisplatin-based chemotherapy for advanced or recurrent cervical cancer.低剂量贝伐单抗联合顺铂化疗对晚期或复发性宫颈癌的协同治疗效果。
J Chin Med Assoc. 2021 Dec 1;84(12):1139-1144. doi: 10.1097/JCMA.0000000000000629.
5
From FIGO-2009 to FIGO-2018 in women with early-stage cervical cancer; Does the revised staging reflect risk groups?从 FIGO-2009 到 FIGO-2018 年,在早期宫颈癌的女性中;修订后的分期是否反映了风险组?
Gynecol Oncol. 2021 Nov;163(2):281-288. doi: 10.1016/j.ygyno.2021.08.026. Epub 2021 Sep 6.
6
Prognostic Factors Associated with 5-Year Overall Survival in Cervical Cancer Patients Treated with Radical Hysterectomy Followed by Adjuvant Concurrent Chemoradiation Therapy at a Tertiary Care Center in Eastern Europe.在东欧一家三级医疗中心接受根治性子宫切除术后辅助同步放化疗的宫颈癌患者中,与5年总生存率相关的预后因素
Diagnostics (Basel). 2021 Mar 22;11(3):570. doi: 10.3390/diagnostics11030570.
7
Recurrence pattern and prognostic factors for survival in cervical cancer with lymph node metastasis.伴有淋巴结转移的宫颈癌的复发模式及生存预后因素
J Obstet Gynaecol Res. 2021 Jun;47(6):2175-2184. doi: 10.1111/jog.14762. Epub 2021 Mar 25.
8
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
9
The Effect of Neoadjuvant Chemotherapy on Lymph Node Metastasis of FIGO Stage IB1-IIB Cervical Cancer: A Systematic Review and Meta-Analysis.新辅助化疗对国际妇产科联盟(FIGO)IB1-IIB期宫颈癌淋巴结转移的影响:一项系统评价和Meta分析
Front Oncol. 2020 Nov 5;10:570258. doi: 10.3389/fonc.2020.570258. eCollection 2020.
10
2018 FIGO Staging Classification for Cervical Cancer: Added Benefits of Imaging.2018 FIGO 宫颈癌分期分类:影像学的附加益处。
Radiographics. 2020 Oct;40(6):1807-1822. doi: 10.1148/rg.2020200013. Epub 2020 Sep 18.